SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-20-013097
Filing Date
2020-07-10
Accepted
2020-07-10 16:40:10
Documents
8
Period of Report
2020-07-10
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm 8-K 41415
2 ex5-1.htm EX-5.1 19479
3 ex10-1.htm EX-10.1 240511
4 ex10-2.htm EX-10.2 109697
5 ex10-3.htm EX-10.3 110966
6 ex99-1.htm EX-99.1 12991
7 ex5-1_001.jpg GRAPHIC 5369
8 ex99-1_001.jpg GRAPHIC 6007
  Complete submission text file 0001493152-20-013097.txt   552245
Mailing Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011
Business Address 2042 CORTE DEL NOGAL CARLSBAD CALIFORNIA CA 92011 (760) 918-9165
Qualigen Therapeutics, Inc. (Filer) CIK: 0001460702 (see all company filings)

IRS No.: 263474527 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37428 | Film No.: 201023536
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences